Literature DB >> 18629447

Types of bone metastases in women with breast cancer undergoing systemic treatments.

V Vassiliou, D Kardamakis, C Cosimo Quattrocchi, P Dell'aia, B Beomonte Zobel.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18629447     DOI： 10.1007/s11547-008-0310-5

Source DB:  PubMed          Journal:  Radiol Med        ISSN： 0033-8362            Impact factor:   3.469


× No keyword cloud information.
  5 in total

1.  The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.

Authors:  G Bonadonna; A Rossi; P Valagussa; A Banfi; U Veronesi
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

2.  A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid.

Authors:  Carlo C Quattrocchi; Daniele Santini; Paola Dell'aia; Sara Piciucchi; Emanuele Leoncini; Bruno Vincenzi; Rosario Francesco Grasso; Giuseppe Tonini; Bruno Beomonte Zobel
Journal:  Skeletal Radiol       Date:  2007-10-03       Impact factor: 2.199

3.  Clinical and radiological evaluation of patients with lytic, mixed and sclerotic bone metastases from solid tumors: is there a correlation between clinical status of patients and type of bone metastases?

Authors:  Vassilios Vassiliou; Christine Kalogeropoulou; Theodoros Petsas; Michael Leotsinidis; Dimitrios Kardamakis
Journal:  Clin Exp Metastasis       Date:  2007-02-13       Impact factor: 4.510

4.  A novel study investigating the therapeutic outcome of patients with lytic, mixed and sclerotic bone metastases treated with combined radiotherapy and ibandronate.

Authors:  Vassilios Vassiliou; Christine Kalogeropoulou; Efstathia Giannopoulou; Michael Leotsinidis; Irine Tsota; Dimitrios Kardamakis
Journal:  Clin Exp Metastasis       Date:  2007-04-18       Impact factor: 4.510

5.  Bone metastases in breast cancer: higher prevalence of osteosclerotic lesions.

Authors:  C C Quattrocchi; S Piciucchi; M Sammarra; D Santini; B Vincenzi; G Tonini; R F Grasso; B B Zobel
Journal:  Radiol Med       Date:  2007-10-21       Impact factor: 6.313
  5 in total
  1 in total

1.  miRNA-128 modulates bone neoplasms cells proliferation and migration through the WNT/β-catenin and EMT signal pathways.

Authors:  Yang Li; Xiaotao Long; Ji Wang; Jing Peng; Kai Shen
Journal:  J Orthop Surg Res       Date:  2021-01-20       Impact factor: 2.359
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.